NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 42 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 6 | -100.0% | 0.00% | – |
| Q4 2019 | $49,000 | -44.9% | 37,008 | -17.3% | 0.00% | – |
| Q3 2019 | $89,000 | – | 44,726 | +171923.1% | 0.00% | – |
| Q2 2019 | $0 | – | 26 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 26 | -79.4% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 126 | -97.4% | 0.00% | – |
| Q3 2018 | $13,000 | -13.3% | 4,858 | +13.0% | 0.00% | – |
| Q2 2018 | $15,000 | -51.6% | 4,301 | -30.9% | 0.00% | – |
| Q1 2018 | $31,000 | -39.2% | 6,220 | -27.7% | 0.00% | – |
| Q4 2017 | $51,000 | – | 8,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |